[ Price : $8.95]
FDA says it will receive until 10/30 joint applications from drug manufacturers and qualified research institutions to be one of 8...[ Price : $8.95]
CDRH launches a new regulatory reliance portal to help foreign regulators use FDA medical device reviews and regulatory decisions ...[ Price : $8.95]
Stakeholders stress issues involving access and safety at an FDA hearing on psychedelic drug regulation.[ Price : $8.95]
FDA agrees to key elements of Rocket Pharmaceuticals modified pivotal Phase 2 trial of RP-A501 for Danon disease, allowing the com...[ Price : $8.95]
Six House members introduce bipartisan legislation to make the FDA Rare Pediatric Disease Priority Review Voucher Program permanen...[ Price : $8.95]
Senate HELP Committee chairman Bill Cassidy (R-La.) keeps mum on any potential support for FDA commissioner nominee Heidi Overton ...[ Price : $8.95]
FDA warns Bausch and Lomb about CGMP violations at its Tampa, FL, drug manufacturing facility.[ Price : $8.95]
AstraZeneca says that its Etcamah (camizestrant) failed to significantly improve progression-free survival in the Phase 3 SERENA-4...